Buchang Pharma's Subsidiary to Set Up Joint Venture

MT Newswires Live
06/10

Shandong Buchang Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.

The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan

Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10